12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ProLease therapeutic protein: Completed Phase I trial enrollment

Alkermes Inc. (ALKS), Cambridge, Mass.
Product: ProLease therapeutic protein
Business: Drug delivery
Therapeutic category: Undisclosed
Target: Undisclosed
Description: Sustained release...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >